Treatment of tumor thrombus in the superior mesenteric vein due to advanced colon cancer with complete surgical resection and chemotherapy: a case report

Tanaka A, Takeda R, Mukaihara S, Hayakawa K, Tasuku K, Terajima H, et al. Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer. J Gastroenterol. 2002;37:220–8. Sato O, Kiba M, Tazoe J, Matsumoto T, Iida S, Morishita H, et al. Examination of Venous tumour thrombus with colorectal cancer by enhanced CT. Rinsho Housyasen. 2010;55:420–6 ((in Japanese)). Tada K, Kokudo N, Seki M, Ueno M, Azekura K, Ohta H, et al. Hepatic resection for colorectal metastasis with macroscopic tumor thrombus in the portal vein. World J Surg. 2003;27:299–303. Otani K, Ishihara S, Hata K, Murono K, Sasaki K, Yasuda K, et al. Colorectal cancer with venous tumor thrombosis. Asian J Surg. 2018;41:197–202. Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy, and response to immunotherapy. J Urol. 2003;169:909–16. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nomomura A, Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106:720–7. Murray D, Hreno A, Dutton J, Hampson LG. Prognosis in colon cancer: a pathologic reassessment. Arch Surg. 1975;110:908–13. Newland RC, Chapuis PH, Pheils MT, MacPherson JG. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer. 1981;47:1424–9. Iida A. The relationship between pathological types and survival of colorectal carcinoma. Nippon Daichokoumonbyou Gakkai Zassi. 1990;43:533–41 ((in Japanese with English abstract)). Rognum TO. CEA, tumour differentiation, and DNA ploidy pattern. Scand J Gastroenterol Suppl. 1988;149:166–78. Hamada Y, Yamamura M, Hioki K, Yamamoto M, Nagura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels. Cancer. 1985;55:136–41. Kaida H, Ishibashi M, Kurata S, Uchida M, Hayabuchi N. Tumor thrombus in the inferior vena cava from colon cancer detected by 18F-FDG-PET. Ann Nucl Med. 2007;21:185–8. Fujii M, Noshima S, Kobayashi T, Enoki T, Zempo N, Esato K. Double colorectal cancer with a tumor thrombosis in the inferior mesenteric vein (IMV)-report of a case. J Jpn Surg Assoc. 2000;61:2701–4 ((in Japanese)). Kawashima K, Endo W, Itakura Y, Wada Y, Yokota K. A case of cancer of the ascending colon with tumor embolism of the superior mesenteric vein. J Jpn Surg Assoc. 2007;68:933–7 ((in Japanese)). Kanzaki A, Hirota M, Okamoto K, Yamashita K, Sato T, Ichihara T. A case of the transverse colon cancer combined with tumor thrombus in superior mesenteric vein and colon perforation. Jpn J Gastroenterol Surg. 2009;42:1436–41 ((in Japanese)). Yamagami H, Masuko H, Kondo Y, Okada K, Ishizu H, Honma S. A case of ascending colon cancer with a tumor thrombosis in superior mesenteric vein: usefulness of CT portography for diagnosis of intraluminal tumor thrombi in the portal vein system. J Jpn Soc Coloproctol. 2009;62:38–43 ((in Japanese)). Kamata A, Hagiwara H, Kano T, Abe Y, Natori J, Uchiyama K. A case report of radical operation for ascending colon cancer with superior mesenteric vein tumor embolus. J Jpn Surg Assoc. 2015;76:2488–92 ((in Japanese)). Tajima Y, Goto H, Akamatsu D, Miyagi S, Kamei T. A case of massive bowel infarction caused by acute superior mesenteric vein occlusion secondary to a tumor thrombus from colon cancer. Jpn J Vasc Surg. 2016;25:57–61 ((in Japanese)). Akabane S, Mukai S, Egi H, Adachi T, Kochi M, Sato K, et al. A case of ascending colon cancer accompanied with tumor thrombosis in the superior mesenteric vein treated with right hemicolectomy and greater saphenous vein grafting. Int J Surg Case Rep. 2018;51:358–63. Kim SE, Lee SJ, Cha JY, Yi SW, Kim TS, Cho IL, et al. Ascending colon cancer with pathologically confirmed tumor thrombosis of superior mesenteric vein: a case report. Clin Endosc. 2019;52:506–9. Greally M, Pilson K, Linehan A, O’Keane C, Shields CJ, Conneely JB, et al. Indolent nodal relapse of colon carcinoma with associated tumor thrombus invading the superior mesenteric vein. J Gastrointest Cancer. 2019;50:660–4. Fujii Y, Kobayashi K, Kimura S, Takiguchi US, S, . Ascending colon cancer accompanied by tumor thrombosis in the superior mesenteric vein: a case report. Int J Surg Case Rep. 2020;73:239–43. Arnould D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, et al. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol. 2017;28:1713–29. Salt LB, Clark S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26:2013–9. Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408–17. Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M, et al. Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Ann Oncol. 2014;25:1346–55. Salvatore L, Cremolini C, Loupakis F, Masi G, Shirrippa M, Marmorino F, et al. Folfoxiri plus bevacizumab (Bv) or plus anti-Egfr antibodies in Ras and Braf wild-type (Wt) metastatic colorectal cancer (Mcrc) patients (Pts): analysis of tumor response. Ann Oncol. 2014;25(Suppl 4):174.